Skip to content

ADXN

Addex Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$3.07
+6.15%
Ask drillr

Margins

Gross margin
-28.8%
EBITDA margin
—
EBIT margin
-5460.8%
Net margin
—
FCF margin
-4994.9%
-359.6%
Return on equity
-197.2%
Return on assets
-130.8%
Return on invested capital
0.01x
Asset turnover
-$2.9M
Cash from operations
$0.53
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026